Your browser doesn't support javascript.
loading
Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAF V600E mutation.
García-Silva, Susana; Benito-Martín, Alberto; Sánchez-Redondo, Sara; Hernández-Barranco, Alberto; Ximénez-Embún, Pilar; Nogués, Laura; Mazariegos, Marina S; Brinkmann, Kay; Amor López, Ana; Meyer, Lisa; Rodríguez, Carlos; García-Martín, Carmen; Boskovic, Jasminka; Letón, Rocío; Montero, Cristina; Robledo, Mercedes; Santambrogio, Laura; Sue Brady, Mary; Szumera-Cieckiewicz, Anna; Kalinowska, Iwona; Skog, Johan; Noerholm, Mikkel; Muñoz, Javier; Ortiz-Romero, Pablo L; Ruano, Yolanda; Rodríguez-Peralto, José L; Rutkowski, Piotr; Peinado, Héctor.
Afiliación
  • García-Silva S; Microenvironment and Metastasis Laboratory, Molecular Oncology Program, Spanish National Cancer Research Center, Madrid, Spain.
  • Benito-Martín A; Children's Cancer and Blood Foundation Laboratories, Department of Pediatrics, Weill Cornell Medicine, New York, NY.
  • Sánchez-Redondo S; Microenvironment and Metastasis Laboratory, Molecular Oncology Program, Spanish National Cancer Research Center, Madrid, Spain.
  • Hernández-Barranco A; Microenvironment and Metastasis Laboratory, Molecular Oncology Program, Spanish National Cancer Research Center, Madrid, Spain.
  • Ximénez-Embún P; Proteomics Unit-ProteoRed-Instituto de Salud Carlos III, Spanish National Cancer Research Center, Madrid, Spain.
  • Nogués L; Microenvironment and Metastasis Laboratory, Molecular Oncology Program, Spanish National Cancer Research Center, Madrid, Spain.
  • Mazariegos MS; Microenvironment and Metastasis Laboratory, Molecular Oncology Program, Spanish National Cancer Research Center, Madrid, Spain.
  • Brinkmann K; Exosome Diagnostics, GmbH, Martinsried, Germany.
  • Amor López A; Microenvironment and Metastasis Laboratory, Molecular Oncology Program, Spanish National Cancer Research Center, Madrid, Spain.
  • Meyer L; Exosome Diagnostics, GmbH, Martinsried, Germany.
  • Rodríguez C; Electron Microscopy Unit, Spanish National Cancer Research Center, Madrid, Spain.
  • García-Martín C; Electron Microscopy Unit, Spanish National Cancer Research Center, Madrid, Spain.
  • Boskovic J; Electron Microscopy Unit, Spanish National Cancer Research Center, Madrid, Spain.
  • Letón R; Hereditary Endocrine Group, Spanish National Cancer Research Center, Madrid, Spain.
  • Montero C; Hereditary Endocrine Group, Spanish National Cancer Research Center, Madrid, Spain.
  • Robledo M; Hereditary Endocrine Group, Spanish National Cancer Research Center, Madrid, Spain.
  • Santambrogio L; Department of Pathology, Microbiology & Immunology, Albert Einstein College of Medicine, New York, NY.
  • Sue Brady M; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Szumera-Cieckiewicz A; Maria Sklodowska-Curie Institute-Oncology Center, Department of Pathology and Laboratory Medicine, Warsaw, Poland.
  • Kalinowska I; Maria Sklodowska-Curie Institute-Oncology Center, Department of Soft Tissue/Bone Sarcoma and Melanoma, Warsaw, Poland.
  • Skog J; Exosome Diagnostics, Inc., Waltham, MA.
  • Noerholm M; Exosome Diagnostics, GmbH, Martinsried, Germany.
  • Muñoz J; Proteomics Unit-ProteoRed-Instituto de Salud Carlos III, Spanish National Cancer Research Center, Madrid, Spain.
  • Ortiz-Romero PL; Department of Dermatology, Medical school, Universidad Complutense de Madrid, Instituto i+12, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Ruano Y; Department of Pathology, Medical school, Universidad Complutense de Madrid, Instituto i+12, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Rodríguez-Peralto JL; Department of Pathology, Medical school, Universidad Complutense de Madrid, Instituto i+12, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Rutkowski P; Maria Sklodowska-Curie Institute-Oncology Center, Department of Soft Tissue/Bone Sarcoma and Melanoma, Warsaw, Poland.
  • Peinado H; Microenvironment and Metastasis Laboratory, Molecular Oncology Program, Spanish National Cancer Research Center, Madrid, Spain hpeinado@cnio.es.
J Exp Med ; 216(5): 1061-1070, 2019 05 06.
Article en En | MEDLINE | ID: mdl-30975894
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Progresión de la Enfermedad / Seroma / Proteínas Proto-Oncogénicas B-raf / Exudados y Transudados / Vesículas Extracelulares / Melanoma / Mutación Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Exp Med Año: 2019 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Progresión de la Enfermedad / Seroma / Proteínas Proto-Oncogénicas B-raf / Exudados y Transudados / Vesículas Extracelulares / Melanoma / Mutación Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Exp Med Año: 2019 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos